"10.1371_journal.pone.0119068","plos one","2015-04-16T00:00:00Z","Bryant Villeponteau; Kennedy Matsagas; Amber C Nobles; Cristina Rizza; Marc Horwitz; Gregory Benford; Robin J Mockett","Genescient Inc., Fountain Valley, California, United States of America; University of California, Irvine, California, United States of America; University of South Alabama, Mobile, Alabama, United States of America","Conceived and designed the experiments: BV CR GB RM. Performed the experiments: KM AN RM. Analyzed the data: BV KM RM. Contributed reagents/materials/analysis tools: MH BV RM. Wrote the paper: BV KM RM.","The authors have the following interests. This study was funded in part by Genescient Corporation. The authors recommended and received approval for publication from the Genescient Board of Directors. Gregory Benford is on the Board. B. Villeponteau received personal income for consulting, and has been granted stock options from Genescient Corporation; he is also an inventor on a patent filing which Genescient has licensed (Pending Patent #14521877). K. Matsagas received compensation from, and has equity in, Genescient Corporation. C. Rizza has equity in Genescient Corporation; she is also an inventor on a patent filing which Genescient has licensed (Pending Patent #14521877). M. Horwitz has equity in Genescient Corporation. G. Benford has equity in Genescient Corporation and serves on the Board of Directors of Genescient Corporation. L.D. Mueller received personal income for consulting from, and has equity in Genescient Corporation. A. Nobles and R. Mockett have no competing interests. The SC100 formulation described herein provides the essential herbal components for several nutritional supplements (e.g. Stem Cell 100) that are currently commercially available and may eventually provide financial benefits to Genescient and its employees and shareholders. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","04","Bryant Villeponteau","BV",7,FALSE,4,3,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
